Local sympathetic denervation in painful diabetic neuropathy

Diabetes

Volumn 51, Issue 12, 2002, Pages 3545-3553

  Tack, Cees J ^a   Van Gurp, Petra J ^a   Holmes, Courtney ^b   Goldstein, David S ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 FLUORODOPA F 18; AMMONIA N 13; NORADRENALIN; TRACER; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; AUTONOMIC DENERVATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEX REGIONAL PAIN SYNDROME; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIAGNOSTIC IMAGING; FEMALE; FOOT PAIN; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROCHEMISTRY; NORADRENALIN BLOOD LEVEL; PAIN; PERFUSION; PERIPHERAL NEUROPATHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; SYMPATHETIC INNERVATION;

EID: 0036895709     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.12.3545     Document Type: Article

References (47)

1. Boulton AJ, Malik RA: Diabetic neuropathy. Med Clin North Am 82:909-929, 1998
2. Ertas M, Sagduyu A, Arac N, Uludag B, Ertekin C: Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy. Pain 75:257-259, 1998
3. Britland ST, Young RJ, Sharma AK, Clarke BF: Acute and remitting painful diabetic polyneuropathy: A comparison of peripheral nerve fibre pathology. Pain 48:361-370, 1992
4. Max MB, Culnane M, Schafer SC, Gracely RH, Walther DJ, Smoller B, Dubner R: Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 37:589-596, 1987
5. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R: Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326:1250-1256, 1992
6. Byas Smith MG, Max MB, Muir J, Kingman A: Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage 'enriched enrollment' design. Pain 60:267-274, 1995
7. Tsigos C, Reed P, Weinkove C, White A, Young RJ: Plasma norepinephrine in sensory diabetic polyneuropathy. Diabetes Care 16:722-727, 1993
8. Ghostine SY, Comair YG, Turner DM, Kassell NF, Azar CG: Phenoxybenzamine in the treatment of causalgia: Report of 40 cases. J Neurosurg 60:1263-1268, 1984
9. Walker SM, Cousins MJ: Complex regional pain syndromes: Including "reflex sympathetic dystrophy" and "causalgia." Anaesth Intensive Care 25:113-125, 1997
10. Birklein F, Riedl B, Claus D, Neundorfer B: Pattern of autonomic dysfunction in time course of complex regional pain syndrome. Clin Auton Res 8:79-85, 1998
11. Boulton AJ, Scarpello JH, Ward JD: Venous oxygenation in the diabetic neuropathic foot: Evidence of arteriovenous shunting? Diabetologia 22:6-8, 1982
12. Flynn MD, Tooke JE: Diabetic neuropathy and the microcirculation. Diabet Med 12:298-301, 1995
13. Purewal TS, Watkins PJ: Postural hypotension in diabetic autonomic neuropathy: A review. Diabet Med 12:192-200, 1995
14. Esler M: Clinical application of noradrenaline spillover methodology: Delineation of regional human sympathetic nervous responses. Pharmacol Toxicol 73:243-253, 1993
15. Goldstein DS, Eisenhofer G, Stull R, Folio CJ, Keiser HR, Kopin IJ: Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. J Clin Invest 81:213-220, 1988
16. Eisenhofer G, Brush JE, Cannon RO 3d, Stull R, Kopin IJ, Goldstein DS: Plasma dihydroxyphenylalanine and total body and regional noradrenergic activity in humans. J Clin Endocrinol Metab 68:247-255, 1989
17. Endo M, Yoshida K, Iinuma TA, Yamasaki T, Tateno Y, Masuda Y, Inagaki Y: Noninvasive quantification of regional myocardial blood flow and ammonia extraction fraction using nitrogen-13 ammonia and positron emission tomography. Ann Nucl Med 1:1-6, 1987
18. Goldstein DS, Holmes C, Stuhlmuller JE, Lenders JWM, Kopin IJ: 6-[18F]fluorodopamine positron emission tomographic scanning in the assessment of cardiac sympathoneural function: Studies in normal humans. Clin Auton Res 7:17-29, 1997
19. Esler MD, Wallin G, Dorward PK, Eisenhofer G, Westerman R, Meredith I, Lambert G, Cox HS, Jennings G: Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans. Am J Physiol 260:RS17-R823, 1991
20. Goldstein DS: Catecholamines in plasma and cerebrospinal fluid: Sources and meanings. In Brain Peptides and Catecholamines in Cardiovascular Regulation in Normal and Disease States. Buckley JP, Ferrario CM, Eds. New York, Raven, 1987, p. 15-25
21. Stanton Hicks M, Janig W, Hassenbusch S, Haddox JD, Boas R, Wilson P: Reflex sympathetic dystrophy: Changing concepts and taxonomy. Pain 63:127-133, 1995
22. Dyck PJ, Zimmerman IR, Johnson DM, Gillen D, Hokanson JL, Karnes JL, Gruener G, O'Brien PC: A standard test of heat-pain responses using CASE IV. J Neurol Sci 136:54-63, 1996
23. Dyck PJ, O'Brien PC, Kosanke JL, Gillen DA, Karnes JL: A 4, 2, and 1 stepping algorithm for quick and accurate estimation of cutaneous sensation threshold. Neurology 43:1508-1512, 1993
24. Goldstein DS, Cannon RO 3rd, Quyyumi A, Chang P, Duncan M, Brush JE Jr, Eisenhofer G: Regional extraction of circulating norepinephrine, DOPA, and dihydroxyphenylglycol in humans. J Auton Nerv Syst 34:17-35, 1991
25. Goldstein DS, Coronado L, Kopin IJ: 6-[Fluorine-18]fluorodopamine pharmacokinetics and dosimetry in humans. J Nucl Med 35:964-973, 1994
26. Holmes C, Eisenhofer G, Goldstein DS: Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl 653:131-138, 1994
27. Goldstein DS, Holmes C, Cannon RO III, Eisenhofer G, Kopin IJ: Sympathetic cardioneuropathy in dysautonomias. N Engl J Med 336:696-702, 1997
28. Eisenhofer G, Goldstein DS, Kopin IJ: Plasma dihydroxyphenylglycol for estimation of noradrenaline neuronal re-uptake in the sympathetic nervous system in vivo. Clin Sci 76:171-182, 1989
29. Eisenhofer G, Rundqvist B, Friberg P: Determinants of cardiac tyrosine hydroxylase activity during exercise-induced sympathetic activation in humans. Am J Physiol 274:R626-R634, 1998
30. Cubells JF, Baker H, Volpe BT, Smith GP, Das SS, Joh TH: Innervation-independent changes in the mRNAs endoding tyrosine hydroxylase and the norepinephrine transporter in rat adrenal medulla after hig-dose reserpine. Neurosci Lett 193:189-192, 1995
31. Netten PM, Wollersheim H, Thien T, Lutterman JA: Skin microcirculation of the foot in diabetic neuropathy. Clin Sci 91:559-565, 1996
32. Tooke JE: Methodologies used in the study of the microcirculation in diabetes mellitus. Diabete Metab Rev 9:57-70, 1993
33. Esler MD, Turner AG, Kaye DM, Thompson JM, Kingwell BA, Morris M, Lambert GW, Jennings GL, Cox HS, Seals DR: Aging effects on human sympathetic neuronal function. Am J Physiol 268:R278-R285, 1995
34. Ng AV, Callister R, Johnson DG, Seals DR: Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension 21:498-503, 1993
35. Hetland ML, Eldrup E, Bratholm P, Christensen NJ: The relationship between age and venous plasma concentrations of noradrenaline, catecholamine metabolites, DOPA, and neuropeptide Y-like immunoreactivity in normal human subjects. Scand J Clin Lab Invest 51:219-224, 1991
36. Scherrer U, Owlya R, Lepori M: Body fat and sympathetic nerve activity. Cardiovasc Drugs Ther 10 (Suppl. 1):215-222, 1996
37. O'Hare JA, Minaker KL, Meneilly GS, Rowe JW, Pallotta JA, Young JB: Effect of insulin on plasma norepinephrine and 3,4-dihydroxyphenylalanine in obese men. Metabolism 38:322-329, 1989
38. Mark AL: The sympathetic nervous system in hypertension: A potential long-term regulator of arterial pressure. J Hypertens 14 (Suppl.):S159-S165, 1996
39. Esler M: Sympathetic nervous system: Contribution to human hypertension and related cardiovascular diseases. J Cardiovasc Pharmacol 26 (Suppl. 2):S24-S28, 1995
40. Karlsson A, Elam M, Lönnroth P, Sullivan L, Friberg P: Differentiated norepinephrine spillover in human skeletal muscle. Am J Physiol 273:R16-R21, 1997
41. Boulton AJ, Ward JD: Diabetic neuropathies and pain. Clin Endocrinol Metab 15:917-931, 1986
42. Ward J: Diabetic peripheral neuropathy. In International Textbook of Diabetes Mellitus. 2nd Ed. Alberti KGMM, Zimmet P, DeFronzo RA, Eds. Chichester, U.K., John Wiley & Sons, 1996, p. 1489-1490
43. Britland ST, Young RJ, Sharma AK, Clarke BF: Association of painful and painless diabetic polyneuropathy with different patterns of nerve fiber degeneration and regeneration. Diabetes 39:898-908, 1990
44. Joslin EP: Diabetic neuropathy. In The Treatment of Diabetes Mellitus. 9th Ed. Joslin EP, Root HF, White P, Marble A, Eds. Philadelphia, Lea & Febiger, 1952, p. 482-483
45. Ahlgren SC, Levine JD: Mechanical hyperalgesia in streptozotocin-diabetic rats is not sympathetically maintained. Brain Res 616:171-175, 1993
46. Ziegler D: Diagnosis and management of diabetic peripheral neuropathy. Diabet Med 13 (Suppl. 1:)S34-S38, 1996
47. Shadiack AM, Vaccariello SA, Sun Y, Zigmond RE: Nerve growth factor inhibits sympathetic neurons' response to an injury cytokine. Proc Natl Acad Sci 95:7727-7730, 1998